Dose delays, dose reductions, and relative dose intensity in patients with cancer who received (neo)adjuvant chemotherapy in community oncology practices.
Menaka Bhor
No relevant relationships to disclose
Xiaoyan Li
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Anne Favret
No relevant relationships to disclose
Phuong Khanh H. Morrow
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Neelima Denduluri
No relevant relationships to disclose
Richard L. Barron
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Shanmugapriya Saravanan
No relevant relationships to disclose
Vincent Girardi
Employment or Leadership Position - Amgen
Consultant or Advisory Role - Amgen
Debra A. Patt
No relevant relationships to disclose
Yanli Li
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Gary H. Lyman
Research Funding - Amgen